Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00885 |
| Species: | Homo sapiens |
| Position : | chr22:41500000-41501000 |
| Year: | 2011 |
| Title: | A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | histiocytic lymphoma |
| PMID: | 21232847 |
| MONDO: | MONDO:0004854 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | RC-K8 |
| CVCL ID: | CVCL_2148 |
| Cell Type: | histiocytic lymphoma cell |
| Cell Ontology ID: | CL:0000576 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | Luciferase reporter assay, ChIP-RT-qPCR, RT-RT-qPCR, siRNA knockdown |
| Target gene : | EP300 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|